Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.
-
Authors
-
-
Loeb, Stacy1
-
Folkvaljon, Yasin2
-
Robinson, David3
-
Lissbrant, Ingela Franck4
-
Egevad, Lars5
-
Stattin, Pär6
-
1
Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, NY, USA. Electronic address: [email protected]
-
2
Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden.
,
(Sweden)
-
3
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden.
,
(Sweden)
-
4
Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden.
,
(Sweden)
-
5
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
,
(Sweden)
-
6
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden; Department of Urology, Uppsala University Hospital, Uppsala, Sweden.
,
(Sweden)
- Type
- Published Article
- Journal
-
European urology
- Publication Date
-
June 2016
- Volume
-
69
- Issue
-
6
- Pages
-
1135–1141
- Identifiers
-
DOI: 10.1016/j.eururo.2015.11.036
-
PMID: 26707871
- Source
-
Medline
- Keywords
-
- License
-
Unknown
Abstract
The new Gleason grade groups, ranging from 1-5, provide a simplified, user-friendly classification system to predict the risk of recurrence after prostatectomy and radiation therapy.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/07/2017 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/26707871
